Full Text View
Tabular View
No Study Results Posted
Related Studies
Open-Label Trial of Leukine in Active Crohn's Disease
This study has been terminated.
Study NCT00206700   Information provided by Bayer
First Received: September 13, 2005   Last Updated: July 8, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Crohn Disease
Additional conditions recognized in this trial
Enteritis
Ileitis
More general conditions related to this trial
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Ileal Diseases
Inflammatory Bowel Diseases
Intestinal Diseases
Interventions listed in this trial
Sargramostim (Leukine, BAY86-5326)
Additional drug interventions recognized in this trial
Molgramostim
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services